Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant

NCT00092937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

NIH

Sponsor class

Conditions

Granulomatous Disease
Chronic

Interventions

DRUG: Busulfan

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)